CDKN3 and glomerular disorder: A marker of mesangial expansion that has been demonstrated to be increased in different types of glomerular diseases is the cell cycle activator p21 (cyclin-dependent kinase inhibitor), the upregulation of which is a direct consequence of the activation of the JAK-STAT pathway [24].